Brought to you by 
CRO ShangPharma nets $44.7mm in IPO
03 May 2012
Executive Summary
Chinese CRO ShangPharma Corp. has netted $44.7mm through its initial public offering of 3.2mm American Depositary Shares at $15 each, on the lower end of the company's $14.50-16.50 range. Each ADS represents 18 ordinary shares. Existing shareholders have also sold 2.6mm ADSs.
Deal Industry
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CRO ShangPharma nets $44.7mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice